Libi Galmer, DO
Neuromusculoskeletal Medicine, Sports Medicine · Jackson Heights, NYNPI 1972731198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Acumed LLC at 24.8% of the total.
Across 21 payments — averaging $41.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acumed LLC$214
- Pacira Therapeutics, Inc.$206
- Medtronic$151
- MML US, Inc.$137
- Amgen$67
- Ferring Pharmaceuticals Inc.$35
- plus $52 from 3 others
What the payments were for
- Food & beverage$861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acumed LLC | 3 | $214 |
| Pacira Therapeutics, Inc. | 5 | $206 |
| Medtronic(2 entities) | 2 | $151 |
| MML US, Inc. | 1 | $137 |
| Amgen | 5 | $67 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Anika Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUMED$146
- InFrame Implant$146
- ReActiv8$137
- KYPHON EXPRESS II KYPHOPAK TRAY$134
- Zilretta$122
How this compares
$861 in reported general payments places this provider in the 65th percentile of 21 neuromusculoskeletal medicine, sports medicine providers in New York.
See all neuromusculoskeletal medicine, sports medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 107 | $3,479 |
| Gabapentin | 135 | $2,103 |
| Tizanidine Hcl | 80 | $756 |
| Meloxicam | 124 | $349 |
| Methocarbamol | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other neuromusculoskeletal medicine, sports medicine in Jackson Heights
- David DinesUniondale$166K
- Jai PerumalNew York$153K
- Marshall KeilsonBrooklyn$8K
- Tracy OnalEast Islip$8K
- Aric HausknechtNew York$3K
- Brian NeriEast Meadow$3K
- Craig TitleNew York$889
- Donald NennoBuffalo$745
- Shaik SanaiOceanside$419
- Jeffrey CohenNew York$269
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.